AntibioticDB

Rifampicin, Rifampin

Rifamycin

Lepetit Pharmaceuticals, IT

1965

Highest development stage: Phase 3
Mechanism of Action/Target pathogen: Antimycobacterial activity against Mycobacterium tuberculosis and Mycobacterium avium
GtoPDB link: https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2765
Source: https://aac.asm.org/content/62/10/e00491-18
Compound/Drug Structure: https://pubchem.ncbi.nlm.nih.gov/compound/135398735